Crossmark

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia

Crossref DOI link: https://doi.org/10.1186/s12974-018-1126-4

Published Online: 2018-03-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sarnelli, Giovanni http://orcid.org/0000-0002-1467-1134
Seguella, Luisa

Pesce, Marcella

Lu, Jie

Gigli, Stefano

Bruzzese, Eugenia

Lattanzi, Roberta

D’Alessandro, Alessandra

Cuomo, Rosario

Steardo, Luca

Esposito, Giuseppe
License Information

Text and Data Mining valid from 2018-03-24
More Information

Article History

Received: 27 October 2017

Accepted: 9 March 2018

First Online: 24 March 2018

Ethics approval

: All procedures were approved by the local University’s Ethics Committee. Animal care was in compliance with the IASP and European Community (EC L358/1 18/12/86) guidelines on the use and protection of animals in experimental research and met stipulations of the guide for the care and use of laboratory animals, as well as recommendations of reduction, refinement, and replacement (known as the 3 Rs).

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.